Ina Oehme
- Molecular Biology top 2%
- Oncology top 2%
- Organic Chemistry top 5%
- Neurology top 5%
- Cancer Research top 10%
- Co-authors
- Olaf WittHedwig E. DeubzerTill MildeMarco LodriniManfred JungWolfgang SipplAndreas von DeimlingAnnette Kopp‐Schneider
- Topics
- Histone Deacetylase Inhibitors Research (43 papers)Protein Degradation and Inhibitors (32 papers)Neuroblastoma Research and Treatments (20 papers)
- Cited by
- Molecular BiologyOncologyGenetics
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyNucleic Acids Research
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Ina Oehme
60 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Biology 3.1k
- Oncology 1.1k
- Organic Chemistry 436
- Neurology 312
- Cancer Research 268
Countries citing papers authored by Ina Oehme
This map shows the geographic impact of Ina Oehme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Oehme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Oehme more than expected).
Fields of papers citing papers by Ina Oehme
This network shows the impact of papers produced by Ina Oehme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Oehme. The network helps show where Ina Oehme may publish in the future.
Co-authorship network of co-authors of Ina Oehme
This figure shows the co-authorship network connecting the top 25 collaborators of Ina Oehme. A scholar is included among the top collaborators of Ina Oehme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Oehme. Ina Oehme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 12 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 7 | |
| 8 | 27 | |
| 9 | 5 | |
| 10 | 18 | |
| 11 | 66 | |
| 12 | 28 | |
| 13 | 40 | |
| 14 | 39 | |
| 15 | 17 | |
| 16 | 37 | |
| 17 | 158 | |
| 18 | 53 | |
| 19 | 320 | |
| 20 | HDAC family: What are the cancer relevant targets?breakdown → | 871 |
About Ina Oehme
Ina Oehme is a scholar working on Neurology, Genetics and Molecular Biology, having authored 65 papers that have together received 3.6k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (43 papers), Protein Degradation and Inhibitors (32 papers) and Neuroblastoma Research and Treatments (20 papers). The work is most often cited by research in Molecular Biology (3.1k citations), Oncology (1.1k citations) and Genetics (261 citations). Ina Oehme has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Olaf Witt, Hedwig E. Deubzer, Till Milde, Marco Lodrini, Manfred Jung, Wolfgang Sippl, Andreas von Deimling, Annette Kopp‐Schneider, Christophe Romier and E Koeneke. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.